ストックスクリーナーアプリを入手
0.3604
5.43%
-0.0207
前日終値:
$0.3811
開ける：
$0.38
24時間の取引高:
427.29K
Relative Volume:
0.03
時価総額：
$17.85M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-27.88%
1か月 パフォーマンス:
+16.26%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.3581
$0.405
1週間の範囲:
$0.3581
$0.5083
52週間の値動き範囲:
$0.215
$2.10
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
名前
Aspire Biopharma Holdings Inc
セクター
電話
561-704-8527
住所
194 CANDELARO DRIVE, #233, HUMACAO
ASBP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.3604 | 18.87M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Aspire Biopharma Holdings Inc (ASBP) 最新ニュース
Aspire Biopharma names new executive chair - MSN
Aspire Biopharma Holdings, Inc. shares rise 2.10% after-hours after unveiling e-commerce platform and launching BUZZ BOMB supplement. - AInvest
What catalysts could drive Aspire Biopharma Holdings Inc. stock higher in 2025Expert Picks Tracker For Beginners - jammulinksnews.com
Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement - ACCESS Newswire
Game-Changing Pre-Workout Supplement Delivers Instant Energy Without Water MixingBUZZ BOMB Hits Market - Stock Titan
Why is Aspire Biopharma Holdings Inc. Equity Warrant stock attracting strong analyst attentionDaily Trading Insights With High Returns - jammulinksnews.com
What makes Aspire Biopharma Holdings Inc. Equity Warrant stock price move sharplyPost Market Outlook For Smart Trading - jammulinksnews.com
Aspire Biopharma Holdings, Inc. Announces CEO Transition - ACCESS Newswire
Aspire Biopharma Leadership Shakeup: Chairman Takes CEO Role Amid Board Restructuring - Stock Titan
ASBP CEO & Audit Chair Resign; Former CEO Returns as Interim | PWUPU SEC FilingForm 8-K - Stock Titan
What catalysts could drive Aspire Biopharma Holdings Inc. Equity Warrant stock higher in 2025Capitalize on fast-moving stock trends - jammulinksnews.com
How many analysts rate Aspire Biopharma Holdings Inc. as a “Buy”Consistent triple returns - jammulinksnews.com
Why is Aspire Biopharma Holdings Inc. stock attracting strong analyst attentionSkyrocketing investment returns - jammulinksnews.com
How does Aspire Biopharma Holdings Inc. compare to its industry peersCapitalize on fast-growing stocks today - jammulinksnews.com
What is the risk reward ratio of investing in Aspire Biopharma Holdings Inc. stockUnlock powerful trading tools for investors - jammulinksnews.com
Is it the right time to buy Aspire Biopharma Holdings Inc. Equity Warrant stockCapitalize on emerging market trends - jammulinksnews.com
How volatile is Aspire Biopharma Holdings Inc. Equity Warrant stock compared to the marketDiscover hidden gems in the stock market - jammulinksnews.com
When is Aspire Biopharma Holdings Inc. stock expected to show significant growthFree Stock Market Mentorship - jammulinksnews.com
What are the latest earnings results for Aspire Biopharma Holdings Inc. Equity WarrantHigh-velocity gains - jammulinksnews.com
What are the technical indicators suggesting about Aspire Biopharma Holdings Inc.Free Market Dynamics Reports - jammulinksnews.com
What are the latest earnings results for Aspire Biopharma Holdings Inc.Get exclusive access to expert stock recommendations - jammulinksnews.com
How does Aspire Biopharma Holdings Inc. Equity Warrant compare to its industry peersExplosive trading opportunities - jammulinksnews.com
Published on: 2025-07-28 05:43:47 - jammulinksnews.com
What is the dividend policy of Aspire Biopharma Holdings Inc. stockBuild a winning portfolio with smart picks - jammulinksnews.com
How volatile is Aspire Biopharma Holdings Inc. stock compared to the marketOutstanding capital returns - jammulinksnews.com
What is Aspire Biopharma Holdings Inc. company’s growth strategyGet professional guidance for market timing - jammulinksnews.com
Is Aspire Biopharma Holdings Inc. Equity Warrant stock overvalued or undervaluedExceptional growth trajectory - jammulinksnews.com
Is Aspire Biopharma Holdings Inc. stock overvalued or undervaluedUnlock expert insights for smarter investing - jammulinksnews.com
Published on: 2025-07-27 20:08:31 - jammulinksnews.com
Published on: 2025-07-27 15:19:42 - jammulinksnews.com
Why FAT Brands Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser
What drives Aspire Biopharma Holdings Inc. Equity Warrant stock priceHigh-performance investment picks - PrintWeekIndia
Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback - MSN
Is Aspire Biopharma Holdings Inc. a good long term investmentAccelerated capital growth - PrintWeekIndia
What analysts say about Aspire Biopharma Holdings Inc. stockDynamic profit expansion - PrintWeekIndia
Aspire Biopharma Holdings Inc (ASBP) 財務データ
Aspire Biopharma Holdings Inc (ASBP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):